AURLUMYN

ILOPROST · BTG International Inc

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AURLUMYN, covering 2024-02-13 to 2024-05-14. Get the full timeline:

Most recent: FDA Approved: AURLUMYN — Supplemental Application (BTG International Inc)